258 related articles for article (PubMed ID: 31410021)
1. Oridonin overcomes the gemcitabine resistant PANC-1/Gem cells by regulating GST pi and LRP/1 ERK/JNK signalling.
Wang B; Shen C; Li Y; Zhang T; Huang H; Ren J; Hu Z; Xu J; Xu B
Onco Targets Ther; 2019; 12():5751-5765. PubMed ID: 31410021
[No Abstract] [Full Text] [Related]
2. Mechanism of metformin enhancing the sensitivity of human pancreatic cancer cells to gem-citabine by regulating the PI3K/Akt/mTOR signaling pathway.
Zhou HY; Yao XM; Chen XD; Tang JM; Qiao ZG; Wu XY
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10283-10289. PubMed ID: 31841183
[TBL] [Abstract][Full Text] [Related]
3. Effects of ribosomal associated protein hnRNP D in gemcitabine-resistant pancreatic cancer.
Wang C; Huang H
Biochem Biophys Res Commun; 2021 Nov; 579():181-187. PubMed ID: 34624736
[TBL] [Abstract][Full Text] [Related]
4. Oridonin enhances the anti-tumor activity of gemcitabine towards pancreatic cancer by stimulating Bax- and Smac-dependent apoptosis.
Liu DL; Bu HQ; Wang WL; Luo H; Cheng BN
Transl Cancer Res; 2020 Jul; 9(7):4148-4161. PubMed ID: 35117784
[TBL] [Abstract][Full Text] [Related]
5. Silencing of IGHG1 reverses the resistance of pancreatic cancer to multidrug chemotherapy by modulating autophagy.
Tian Y; Han W; Fu L; Lv K; Zhou X
Environ Toxicol; 2023 Aug; 38(8):1835-1845. PubMed ID: 37186415
[TBL] [Abstract][Full Text] [Related]
6. [A novel chemo-resistant gene MSX2 discovered by establishment of two pancreatic cancer drug resistant cell lines JF305/CDDP and PANC-1/GEM].
Yuan W; Sui CG; Ma X; Ma J
Zhonghua Zhong Liu Za Zhi; 2018 May; 40(5):330-334. PubMed ID: 29860758
[No Abstract] [Full Text] [Related]
7. Thymoquinone affects the gemcitabine sensitivity of pancreatic cancer by regulating collagen via hypoxia inducible factor-1α.
Zhao Z; Liu L; Chen H; Li S; Guo Y; Hou X; Yang J
Front Pharmacol; 2023; 14():1138265. PubMed ID: 37324458
[No Abstract] [Full Text] [Related]
8. microRNA-218 promotes gemcitabine sensitivity in human pancreatic cancer cells by regulating HMGB1 expression.
Liu Z; Du R; Long J; Guo K; Ge C; Bi S; Xu Y
Chin J Cancer Res; 2015 Jun; 27(3):267-78. PubMed ID: 26157323
[TBL] [Abstract][Full Text] [Related]
9. Triptolide enhances the sensitivity of pancreatic cancer PANC-1 cells to gemcitabine by inhibiting TLR4/NF-κB signaling.
Ma JX; Sun YL; Yu Y; Zhang J; Wu HY; Yu XF
Am J Transl Res; 2019; 11(6):3750-3760. PubMed ID: 31312385
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of lncRNA AFAP1-AS1 by oridonin inhibits the epithelial-to-mesenchymal transition and proliferation of pancreatic cancer cells.
Lou S; Xu J; Wang B; Li S; Ren J; Hu Z; Xu B; Luo F
Acta Biochim Biophys Sin (Shanghai); 2019 Aug; 51(8):814-825. PubMed ID: 31314060
[TBL] [Abstract][Full Text] [Related]
11. Knockdown of serine/threonine protein phosphatase 5 enhances gemcitabine sensitivity by promoting apoptosis in pancreatic cancer cells
Zhu J; Ji Y; Yu Y; Jin Y; Zhang X; Zhou J; Chen Y
Oncol Lett; 2018 Jun; 15(6):8761-8769. PubMed ID: 29805615
[TBL] [Abstract][Full Text] [Related]
12. Co-delivery of gemcitabine and Triapine by calcium carbonate nanoparticles against chemoresistant pancreatic cancer.
Zhao Y; Zheng Y; Zhu Y; Ding K; Zhou M; Liu T
Int J Pharm; 2023 Apr; 636():122844. PubMed ID: 36925025
[TBL] [Abstract][Full Text] [Related]
13. [X-linked inhibitor of apoptosis protein (XIAP) and Survivin suppression on human pancreatic cancer cells Panc-1 proliferation and chemosensitivety].
Zai HY; Yi XP; Li YX; You XY; Cao LP; Liu H
Beijing Da Xue Xue Bao Yi Xue Ban; 2013 Apr; 45(2):242-9. PubMed ID: 23591345
[TBL] [Abstract][Full Text] [Related]
14. Oridonin inhibition and miR‑200b‑3p/ZEB1 axis in human pancreatic cancer.
Gui Z; Luo F; Yang Y; Shen C; Li S; Xu J
Int J Oncol; 2017 Jan; 50(1):111-120. PubMed ID: 27878247
[TBL] [Abstract][Full Text] [Related]
15. [Experimental study on anti-pancreatic cancer effect of oridonin].
Wang H; Wang YF; Liu TG; Xiang XL; Huang SL
Zhong Yao Cai; 2014 Jul; 37(7):1230-3. PubMed ID: 25566662
[TBL] [Abstract][Full Text] [Related]
16. CircHIPK3 Promotes Gemcitabine (GEM) Resistance in Pancreatic Cancer Cells by Sponging miR-330-5p and Targets RASSF1.
Liu Y; Xia L; Dong L; Wang J; Xiao Q; Yu X; Zhu H
Cancer Manag Res; 2020; 12():921-929. PubMed ID: 32104074
[TBL] [Abstract][Full Text] [Related]
17. Proteomic analysis of gemcitabine-induced drug resistance in pancreatic cancer cells.
Chen YW; Liu JY; Lin ST; Li JM; Huang SH; Chen JY; Wu JY; Kuo CC; Wu CL; Lu YC; Chen YH; Fan CY; Huang PC; Law CH; Lyu PC; Chou HC; Chan HL
Mol Biosyst; 2011 Nov; 7(11):3065-74. PubMed ID: 21894339
[TBL] [Abstract][Full Text] [Related]
18. Gemcitabine-Loaded Albumin Nanoparticle Exerts An Antitumor Effect on Gemcitabine-Resistant Pancreatic Cancer Cells Induced by MDR1 and MRP1 Overexpression in Vitro.
Kong L; Du J; Gu J; Deng J; Guo Y; Tao B; Jin C; Fu D; Li J
Front Surg; 2022; 9():890412. PubMed ID: 35656085
[TBL] [Abstract][Full Text] [Related]
19. Co-Delivery of Gemcitabine and Mcl-1 SiRNA via Cationic Liposome-Based System Enhances the Efficacy of Chemotherapy in Pancreatic Cancer.
Wang Y; Gao F; Jiang X; Zhao X; Wang Y; Kuai Q; Nie G; He M; Pan Y; Shi W; Ren S; Yu Q
J Biomed Nanotechnol; 2019 May; 15(5):966-978. PubMed ID: 30890228
[TBL] [Abstract][Full Text] [Related]
20. Emodin alleviates gemcitabine resistance in pancreatic cancer by inhibiting MDR1/P-glycoprotein and MRPs expression.
Guo H; Liu F; Yang S; Xue T
Oncol Lett; 2020 Nov; 20(5):167. PubMed ID: 32934734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
